Skip to main content
. 2011 Nov 23;2012:509730. doi: 10.1155/2012/509730

Table 5.

Emergency room visit, total hospital admissions, blood eosinophils, and serum IgE in patient subgroups before and after carnitine supplementation and the placebo group.

Subgroup A (with L-Carnitine)
(n = 25)
Subgroup B (Placebo)
(n = 25)
t P
Emergency room visit bef. 3.1 ± 1.01 3.4 ± 1.0 1.2 >0.05
aft 1.5 ± 0.6 2.6 ± 0.9 4.68 <0.001*

Total Hospital admissions bef. 1.5 ± 0.6 1.8 ± 0.7 1.9 >0.05
aft 0.44 ± 0.5 1.8 ± 0.6 7.5 <0.001*

Oral steroid bef. 2.16 ± 0.74 2.12 ± 0.72 0.21 >0.05
aft 1.2 ± 0.5 1.6 ± 0.5 2.8 <0.01*

Serum IgE (kU/L) bef. 328 ± 89 322 ± 114 0.21 >0.05
aft 253 ± 62 290 ± 106 1.6 >0.05

Blood eosinophils (%) bef. 5.8 ± 2.1 6.04 ± 2.1 0.38 >0.05
aft 3.1 ± 0.8 4.4 ± 1.2 4.2 <0.001*

(*) P < 0.05 is significant There were significant decreases in the frequency of emergency room visit, total hospital admissions, and the intake of oral steroids between L-Carnitine-supplemented children compared to placebo group during the study period. The blood eosinophils % decreased significantly after treatment with L-Carnitine in asthmatic group. It was significantly lower in L-Carnitine treatment group than in placebo group. Serum Ig E showed no significant difference in treatment and placebo group (both before and after treatment).